# A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy

> **NCT01438567** · PHASE3 · COMPLETED · sponsor: **Mundipharma Research GmbH & Co KG** · enrollment: 270 (actual)

## Conditions studied

- Pain
- Constipation

## Interventions

- **DRUG:** oxycodone/naloxone prolonged release (OXN PR) tablets
- **DRUG:** oxycodone prolonged release (OxyPR) tablets

## Key facts

- **NCT ID:** NCT01438567
- **Lead sponsor:** Mundipharma Research GmbH & Co KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-09
- **Target enrollment:** 270 (ACTUAL)
- **Last updated:** 2018-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438567, "A Study to Demonstrate Improvement in Symptoms of Constipation in Subjects That Require Around-the-clock Opioid Pain Killer Therapy". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01438567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*